This email notification is intended as a heads up to OHSU communicators. It is not shared with external subscribers.
|
Newly approved drug is effective in patients with prostate cancerApalutamide significantly delayed the onset of symptoms, metastasis or death in Phase III clinical trial.
|
|
This email was sent to you by Oregon Health & Science University 3181 S.W. Sam Jackson Park Rd. | Portland, Oregon 97239-3098 |